Company Name:Kura Oncology Inc.
CEO: Troy E. Wilson

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: Kura Oncology Inc is a clinical stage biopharmaceutical company, engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers.


Key numbers

Market Capitalization:578219400
Shares Outstanding: 45315000
Float: 40837244
Next Earning Date:2020-03-11
TTm EPS: -1.5341
TTm Dividend Rate:
200 days moving average:16.22
50 days moving average: 14.59
One day percent Change: -0.86



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,